Monocyte/macrophage expression of ABCA1 has minimal contribution to plasma HDL levels
AUTOR(ES)
Haghpassand, Mehrdad
FONTE
American Society for Clinical Investigation
RESUMO
Excess accumulation of cholesterol in macrophages results in foam cell production and lesion development. Recent studies have demonstrated that ATP-binding cassette protein A1 (ABCA1) is highly regulated in macrophages and mediates the efflux of cholesterol and phospholipids to apolipoproteins, a process necessary for HDL formation. The goal of this study was to determine the contribution of monocyte/macrophage ABCA1 to HDL formation in vivo. We generated mice expressing ABCA1 in macrophages and mice with selected inactivation of ABCA1 in macrophages by bone marrow transplantation in ABCA1-deficient (ABC1–/–) and wild-type (WT) mice. At all times, the level of HDL in ABC1–/– recipient mice remained low relative to WT recipient mice irrespective of the genotype of the donor macrophage ABCA1 or high-fat feeding. Expression of WT macrophage ABCA1 in ABC1–/– mice resulted in a small but significant increase in apoA-I levels starting 2 weeks after transplantation. No further increase in apoAI was observed up to 14 weeks after transplantation. The increase in apoAI was accompanied by a small but significant increase in HDL cholesterol 6 weeks after transplantation. The HDL formed as a consequence of the expression of WT macrophage ABCA1 migrated to the alpha position in a two-dimensional gel electrophoresis. These results demonstrate that monocyte/macrophage ABCA1 contributes to HDL formation; however, the contribution to the overall plasma HDL levels is minimal.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=209438Documentos Relacionados
- Tumor necrosis factor-alpha modulates monocyte/macrophage apoprotein E gene expression.
- Human cytomegalovirus infection of the monocyte/macrophage lineage in bone marrow.
- Do DNA sequence variants in ABCA1 contribute to HDL cholesterol levels in the general population?
- CNI-1493 inhibits monocyte/macrophage tumor necrosis factor by suppression of translation efficiency.
- Ber-MAC3: new monoclonal antibody that defines human monocyte/macrophage differentiation antigen.